Our disease groups feature a trio of leaders representing clinical care, clinical research and basic research. These leaders work together to promote and advance the diagnosis, treatment and continuing care of cancer patients.
#NEWS: Duke researchers reveal a promising new approach, which is likely to be tested in #clinicaltrials w/ in the year. The research identified & targeted vulnerabilities that appear in nearly all estrogen-positive #breastcancer's that develop resistance. https://t.co/qcdDpf64SE